September 20, 2018 / TheNewswire / Vancouver, BC – AREV Brands International Ltd. (CSE: AREV), is pleased to announce that it has reached a major milestone in its joint development project with Alternative Extracts Inc. The research work conducted was with oil based extracts from non regulated sources that carry a wide variety of terpenes and related compounds responsible for aroma and flavour. Terpene synthesis is vital for cannabinoid synthesis as it provides the GPP molecule for CBGA synthesis.
The company through its proprietary extraction methods has discovered an efficient way to infuse aqueous solutions with oil based extracts that include some flavonoids and terpenes. These extracts were infused in non-alcoholic beer, ciders, wine, spritzers, fruit juices and maple water.
The materials used include Hops, Frankincense, Myrrh, Pepper, Lemon Balm, Lavender, Tea Tree oil, Turmeric and oil from hemp seeds. The company has sampled enough material to be confident that
it can extract virtually any lipid based terpene and infuse it into an aqueous based product.
These materials contain many valuable terpenes that affect mood and experience when combined with THC. Many of these terpenes are destroyed in the decarboxylation process that is performed to activate THC.
AREV can now preserve the valuable terpenes found in medicinal plants while also having the potential to serve as a natural preservative. This is key in non alcoholic beers, which have a short shelf life, and will be of use in other AREV products. We can also create flavour profiles with the flavonoid and terpene extracts and in some cases amplify the entourage effect.
AREV invites any Health Canada Licensed Producer or beverage manufacturers to contact the company for further discussions on this breakthrough that will dramatically reduce their product development cycle.
Mike Withrow commented "We are ecstatic about this discovery and how the purity and quality of the extracts from the extraction system are performing. It is potentially a game changer for those incumbents in the cannabis and beverage space."
Dr. Adrian Wade, Chief Science Officer, of Alternative Extracts Inc. commented "AREV’s extractors produce the highest quality products, including terpenes. Terpenes provide distinctive aromas in plants and play an important role in an increasing number of health food products. The ability to readily infuse pure, naturally sourced terpenes into beverages provides the consumer with aromas that are closest to nature."
The Company announces it has settled $ 150,000 in debt with Alternative Extracts Inc. by the issuance of 500,000 Shares at $ 0.30. Alternative Extracts Inc. is a reporting issuer and the majority of the shares of Alternative Extracts are held by Mike Withrow, a director of the Company. The Company has issued 300,000 stock options to Directors and Consultants of the Company at a price of $ 0.325 for a period of 5 years from the issuance date. These options will vest immediately.
Participation of the insiders of the Company in the shares for debt constitutes a related party transaction as defined under Multilateral Instrument 61-101 (Protection of Minority Security Holders in Special Transactions). Because the Company’s shares trade only on the CSE, the issuance of securities is exempt from the formal valuation requirements of Section 5.4 of MI 61-101 pursuant to Subsection 5.5(b) of MI 61-101 and exempt from the minority approval requirements of Section 5.6 of MI 61-101 under 5.7(b).
For further information, contact Mike Withrow, at email@example.com.
On behalf of the Board,
Chairman & Director
About AREV Nutrition Sciences Inc.
AREV Nutrition Sciences Inc. ("AREV") produces and delivers functional ingredients from its world-class extraction systems. AREV is revolutionizing the current delivery method of coconut oil, whey protein and nutrients through emulsification. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV is also working with Pharmacy and Dispensary operators with an innovative emulsified base formula to disperse Cannabis oil extracts from specific selected genetic Cannabis strains that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on www.sedar.com.
Copyright (c) 2018 TheNewswire – All rights reserved.